Previous close | 131.60 |
Open | 0.00 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | 169,331 |
Market cap | 333.43B |
Beta (5Y monthly) | 0.38 |
PE ratio (TTM) | 107.70 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.92 (2.83%) |
Ex-dividend date | 14 Sept 2023 |
1y target est | N/A |
Merck (MRK) stock is being driven by the strong sales of key products like Keytruda and Gardasil and positive pipeline and regulatory developments.
American Express, Walmart, Amazon, The Goldman Sachs and Merck & Co are included in this Analyst Blog.
The fact that multiple Merck & Co., Inc. ( NYSE:MRK ) insiders offloaded a considerable amount of shares over the past...